On February 15, 2016 Sandoz together with leading global charity World Child Cancer (WCC), reported a new health initiative in the Philippines, aimed at improving the standard of care for children suffering from cancer (Press release, Sandoz, FEB 15, 2016, View Source [SID:1234510072]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cancer survival rates for children in the Philippines are less than 20%, compared to an average of 80% in developed countries. The goal of the new partnership, further details of which will be announced next month, is to help "even the odds" by supporting the development of specialist treatment centers in the island region of Mindanao.
Paul Geymayer, Sandoz regional head for Asia-Pacific, says: "This pilot project will take simple, pragmatic measures to attack cancer where it is most vulnerable: among underprivileged children suffering from forms of cancer that are absolutely treatable if given access to medicines, medical information and professional healthcare. Our goal is to make cancer care accessible to more children on the island, enhance the standard of care and improve survival rates."
Jon Rosser, World Child Cancer CEO adds: "In the Philippines, there are approximately 3,500 new cases of childhood cancer every year, with two-thirds diagnosed only at advanced stages. More than 80% of patients live too far away from a treatment center to access the care they need and many are forced to discontinue treatment due to costs and travel difficulties. "However, many of these cases are curable and this project will help to ensure that these children are able to access the care they need".
The WCC partnership highlights Sandoz’s commitment to address key global healthcare challenges by pioneering new approaches to increase access to medicine.